COMP <GO>
XMAX vs HELE // REVENUE GROWTH (YOY)
XMAX Inc. (NASDAQ) VS. Helen of Troy Limited (NASDAQ) • 15-METRIC TALLY: XMAX 4
— HELE 5
▲ REVENUE GROWTH (YOY) LEADER: XMAX
LAST: $8.09 (-0.98%) • MKT CAP: $524.8M
revenue-growth
72.60%
LAST: $29.71 (+1.37%) • MKT CAP: $694.9M
revenue-growth
-6.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XMAX VS. HELE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XMAX | HELE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.00% | 45.70% | -20.70 | HELE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -5.80% | -35.00% | +29.20 | XMAX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.08% | 24.63% | -24.71 | HELE | /fcf-yield <GO> |
| Operating Margin | -11.50% | -43.80% | +32.30 | XMAX | /operating-margins <GO> |
| Net Profit Margin | -20.40% | -50.30% | +29.90 | XMAX | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 72.60% | -6.40% | +79.00 | XMAX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.45 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | HELE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 19.2 | 52.9 | -33.71 | HELE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $524.8M | $694.9M | -$170.1M | HELE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XMAX REV | HELE REV | XMAX GROSS % | HELE GROSS % | XMAX FCF | HELE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.7M | $1.79B | 25.0% | 45.7% | -$445.8K | $171.1M |
| FY 2024 | $9.7M | $1.91B | 43.9% | 47.9% | -$1.4M | $113.2M |
| FY 2023 | $11.1M | $2.01B | — | — | -$1.6M | $306.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XMAX // BETA —
HELE // BETA —